Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, recently announced the launch of its cost-effective GalNAc (TEG)-CPG reagent to empower the development of nucleic acid therapeutics. This reagent is used to synthesize oligonucleotide-GalNAc conjugates.   Asialoglycoprotein receptor (ASGPR) is the ideal target...